Bulletin
Investor Alert

Market Pulse Archives

July 29, 2021, 6:49 a.m. EDT

Merck stock slips after adjusted profit matches expectations, while revenue beats

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Merck & Co. Inc. (MRK)
  • X
    Dow Jones Industrial Average (DJIA)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Shares of Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -3.79% fell 0.9% in premarket trading Thursday, after the drug maker reported second-quarter adjusted profit that matched expectations, while sales rose above forecasts even as Keytruda sales came up short. Net income fell to $1.55 billion, or 61 cents a share, from $3.00 billion, or $1.18 a share, in the year-ago period. Excluding nonrecurring items, such as a $1.7 billion charge for the acquisition of Pandion Therapeutics, adjusted earnings per share rose to $1.31 from $1.02 to match the FactSet consensus of $1.31. Sales grew 19% to $11.40 billion, above the FactSet consensus of $11.08 billion. Pharmaceutical sales rose 22% to $9.98 billion, while sales of its key cancer treatment Keytruda increased 23% to $4.18 billion but missed expectations of $4.35 billion. For 2021, the company expects adjusted EPS of $5.47 to $5.57, surrounding the FactSet consensus of $5.52, and expects revenue of $46.4 billion to $47.4 billion, above expectations of $46.2 billion. Merck's stock has edged up 0.4% year to date through Wednesday, while the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -2.53% has gained 14.1%.

/zigman2/quotes/209956077/composite
US : U.S.: NYSE
$ 79.16
-3.12 -3.79%
Volume: 18.02M
Nov. 26, 2021 1:10p
P/E Ratio
27.95
Dividend Yield
3.28%
Market Cap
$207.83 billion
Rev. per Employee
$648,824
loading...
/zigman2/quotes/210598065/realtime
US : Dow Jones Global
34,899.34
-905.04 -2.53%
Volume: 325.39M
Nov. 26, 2021 2:12p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.